Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. (2021)
Attributed to:
MRC Pandemic Preparedness Funding – The Francis Crick Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bcj20210198
PubMed Identifier: 34198326
Publication URI: http://europepmc.org/abstract/MED/34198326
Type: Journal Article/Review
Volume: 478
Parent Publication: The Biochemical journal
Issue: 13
ISSN: 0264-6021